These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6085299)

  • 21. Distribution of natural killer cell activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vitro treatment with interferon preparation.
    Antonelli P; Stewart W; Dupont B
    Clin Immunol Immunopathol; 1981 May; 19(2):161-9. PubMed ID: 6164514
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells by gamma interferon.
    Triozzi PL; Sedwick WD; Iland HJ; Richards RG; Laszlo J
    J Biol Response Mod; 1986 Dec; 5(6):562-70. PubMed ID: 3098928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of measuring the interferon-induced enzyme 2'-5'-oligoadenylate synthetase in children.
    Huppertz HI; Becker K; Kreth HW
    Acta Paediatr; 1992 Apr; 81(4):329-34. PubMed ID: 1376630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Umbilical-cord-blood-derived suppressor cells of the human natural killer cell activity are inhibited by interferon.
    Tarkkanen J; Saksela E
    Scand J Immunol; 1982 Feb; 15(2):149-57. PubMed ID: 6179151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of influenza A infection on umbilical cord blood natural killer function regulation with interleukin-15.
    Lin SJ; Cheng PJ; Lin TY; Lee PT; Hsiao HS; Kuo ML
    J Infect Dis; 2012 Mar; 205(5):745-56. PubMed ID: 22262794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human newborns are deficient in natural killer activity.
    Kaplan J; Shope TC; Bollinger RO; Smith J
    J Clin Immunol; 1982 Oct; 2(4):350-5. PubMed ID: 6183291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.
    Schattner A; Merlin G; Bregman V; Hahn T; Levin S; Revel M; Wallach D
    Clin Exp Immunol; 1984 Aug; 57(2):265-70. PubMed ID: 6467673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the 2'-5' A pathway in the augmentation of natural killer activity.
    Schmidt A; Crisp B; Krause D; Silverman RH; Herberman RB; Ortaldo JR
    Nat Immun Cell Growth Regul; 1987; 6(1):19-27. PubMed ID: 2437444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity.
    Montagna D; Maccario R; Ugazio AG; Mingrat G; Burgio GR
    Clin Exp Immunol; 1988 Jan; 71(1):177-81. PubMed ID: 2964956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships of prostaglandin levels and natural killer (NK) cell cytotoxicity of mononuclear cells in cord blood.
    Ching CY; Ching N; Seto DS; Hokama Y
    J Med; 1984; 15(3):233-6. PubMed ID: 6597256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of human neonatal natural killer cytotoxicity to herpes simplex virus with use of recombinant human interferons: lack of neonatal response to gamma interferon.
    Oh SH; Gonik B; Greenberg SB; Kohl S
    J Infect Dis; 1986 Apr; 153(4):791-3. PubMed ID: 3005439
    [No Abstract]   [Full Text] [Related]  

  • 33. [Induction of interferon-specific enzymes in cultures of cells sensitive and resistant to interferon].
    Narovlianskiĭ AN; Turpaev KT; Amchenkova AM; Itkes AV; Alimov EG
    Mol Gen Mikrobiol Virusol; 1988 Feb; (2):34-9. PubMed ID: 2453797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of maternal and neonatal natural killer cell activity with interleukin-2.
    Baker DA; Milch PO; Salvatore W; Luft B
    Am J Obstet Gynecol; 1987 Sep; 157(3):780-1. PubMed ID: 3498365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cord IgM antibody specific for human killer T cells: T lymphocytotoxic human fetal antibody (TLFA) recognizing maternal killer T cells proliferating in the presence of interleukin 2.
    Miyagawa Y; Komiyama A; Akabane T; Uehara Y; Yano A
    J Immunol; 1982 Nov; 129(5):1993-6. PubMed ID: 6981670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring of interferon treatment in patients with renal cell carcinoma and bladder carcinoma by oligo-A synthetase assay and determination of immunological parameters.
    Grups JW; Komprecht B
    J Biol Regul Homeost Agents; 1989; 3(3):98-101. PubMed ID: 2516404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
    Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon and 2-5A synthetase in patients with immune diseases.
    Preble OT; Yeh TJ; Silverman RH; Klippel JH; Straus SE; Gelmann EP
    Prog Clin Biol Res; 1985; 202():415-22. PubMed ID: 2421319
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway.
    Han P; McDonald T; Hodge G
    Immunology; 2004 Sep; 113(1):26-34. PubMed ID: 15312133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of the changes in the natural killer activity of peripheral blood lymphocytes during pregnancy].
    Shalakhova OV; Malygin AM; Fel' VIa
    Tsitologiia; 1987 Aug; 29(8):942-7. PubMed ID: 3686670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.